Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01079780||Active, not recruiting||Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy||
||Other / NIH||
||135||All||18 Years to 120 Years (Adult, Senior)||NCT01079780||CDR0000666736
|October 8, 2010||July 1, 2018||July 1, 2023||March 3, 2010||December 14, 2017||